HIGHLIGHTS
- who: Yang-Bao Miao from the Department of Haematology, Sichuan Academy of Medical and Sichuan Provincial Peopleu2019s Hospital, School of Medicine of University First Ring Road, Qingyang District, Chengdu, China have published the paper: Customizing delivery nano-vehicles for precise brain tumor therapy, in the Journal: (JOURNAL)
- what: As a monotherapy and in combination with trastuzumab, a monoclonal antibody that interferes with the human epidermal growth factor receptor, the goal of the trial was to investigate the safety, tolerability, and pharmacokinetics of 2B3-101. In contrast to lipid nanovesicles, the approach of molecular design is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.